Cargando…
Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report
BACKGROUND: Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms of uncertain malignant potential, which have in common the co-expression of muscle and melanocytic immunohistochemical markers. CASE PRESENTATION: A 48-year-old man presented with dysuria, passage of urinary se...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564030/ https://www.ncbi.nlm.nih.gov/pubmed/16925812 http://dx.doi.org/10.1186/1471-2490-6-20 |
_version_ | 1782129537321009152 |
---|---|
author | Parfitt, Jeremy R Bella, Anthony J Wehrli, Bret M Izawa, Jonathan I |
author_facet | Parfitt, Jeremy R Bella, Anthony J Wehrli, Bret M Izawa, Jonathan I |
author_sort | Parfitt, Jeremy R |
collection | PubMed |
description | BACKGROUND: Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms of uncertain malignant potential, which have in common the co-expression of muscle and melanocytic immunohistochemical markers. CASE PRESENTATION: A 48-year-old man presented with dysuria, passage of urinary sediment and lower abdominal discomfort. A three centimeter mass was identified by cystoscopy in the posterior midline of the bladder. Computerized tomography suggested an enterovesical fistula. The patient underwent laparotomy, partial cystectomy and partial small bowel resection. Pathological examination revealed PEComa of the bladder. The patient underwent adjuvant interferon-α immunotherapy. Subsequent follow-up procedures, including cystoscopy and imaging, have not revealed evidence of recurrence. The patient is clinically free of disease 48 months after surgery. CONCLUSION: This case represents the second documented PEComa of bladder and demonstrates that adjuvant therapies, including anti-angiogenic and immunotherapy, may be considered for patients with locally advanced or metastatic genitourinary PEComa. |
format | Text |
id | pubmed-1564030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-15640302006-09-12 Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report Parfitt, Jeremy R Bella, Anthony J Wehrli, Bret M Izawa, Jonathan I BMC Urol Case Report BACKGROUND: Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms of uncertain malignant potential, which have in common the co-expression of muscle and melanocytic immunohistochemical markers. CASE PRESENTATION: A 48-year-old man presented with dysuria, passage of urinary sediment and lower abdominal discomfort. A three centimeter mass was identified by cystoscopy in the posterior midline of the bladder. Computerized tomography suggested an enterovesical fistula. The patient underwent laparotomy, partial cystectomy and partial small bowel resection. Pathological examination revealed PEComa of the bladder. The patient underwent adjuvant interferon-α immunotherapy. Subsequent follow-up procedures, including cystoscopy and imaging, have not revealed evidence of recurrence. The patient is clinically free of disease 48 months after surgery. CONCLUSION: This case represents the second documented PEComa of bladder and demonstrates that adjuvant therapies, including anti-angiogenic and immunotherapy, may be considered for patients with locally advanced or metastatic genitourinary PEComa. BioMed Central 2006-08-22 /pmc/articles/PMC1564030/ /pubmed/16925812 http://dx.doi.org/10.1186/1471-2490-6-20 Text en Copyright © 2006 Parfitt et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Parfitt, Jeremy R Bella, Anthony J Wehrli, Bret M Izawa, Jonathan I Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report |
title | Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report |
title_full | Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report |
title_fullStr | Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report |
title_full_unstemmed | Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report |
title_short | Primary PEComa of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report |
title_sort | primary pecoma of the bladder treated with primary excision and adjuvant interferon-alpha immunotherapy: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564030/ https://www.ncbi.nlm.nih.gov/pubmed/16925812 http://dx.doi.org/10.1186/1471-2490-6-20 |
work_keys_str_mv | AT parfittjeremyr primarypecomaofthebladdertreatedwithprimaryexcisionandadjuvantinterferonalphaimmunotherapyacasereport AT bellaanthonyj primarypecomaofthebladdertreatedwithprimaryexcisionandadjuvantinterferonalphaimmunotherapyacasereport AT wehrlibretm primarypecomaofthebladdertreatedwithprimaryexcisionandadjuvantinterferonalphaimmunotherapyacasereport AT izawajonathani primarypecomaofthebladdertreatedwithprimaryexcisionandadjuvantinterferonalphaimmunotherapyacasereport |